Literature DB >> 11134510

Oligomerization of opioid receptors with beta 2-adrenergic receptors: a role in trafficking and mitogen-activated protein kinase activation.

B A Jordan1, N Trapaidze, I Gomes, R Nivarthi, L A Devi.   

Abstract

G-protein-coupled receptors (GPCRs) have recently joined the list of cell surface receptors that dimerize. Dimerization has been shown to alter the ligand-binding, signaling, and trafficking properties of these receptors. Recent studies have shown that GPCRs heterodimerize with closely related members, resulting in the modulation of their function. In this study, we have attempted to determine whether members of GPCR superfamilies that couple to different families of G-proteins can associate and form oligomers. We chose the beta2 adrenergic receptor that couples to stimulatory G-proteins and delta & kappa opioid receptors that couple to inhibitory G-proteins. beta2 and delta receptors undergo robust agonist-mediated endocytosis, whereas kappa receptors do not. We find that when coexpressed, beta2 receptors can form heteromeric complexes with both delta and kappa receptors. This heterooligomerization does not significantly alter the ligand binding or coupling properties of the receptors. However, it affects the trafficking properties of the receptors. For example, we find that delta receptors, when coexpressed with beta2 receptors, undergo isoproterenol-mediated endocytosis. Conversely, beta2 receptors in these cells undergo etorphine-mediated endocytosis. However, beta2 receptors, when coexpressed with kappa receptors, undergo neither opioid- nor isoproterenol-mediated endocytosis. Moreover, these cells exhibit a substantial decrease in the isoproterenol-induced phosphorylation of mitogen-activated protein kinases. Taken together, these results provide direct evidence of heteromerization of GPCRs that couple to different types of G-proteins, which results in the modulation of receptor trafficking and signal transduction.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11134510      PMCID: PMC14592          DOI: 10.1073/pnas.98.1.343

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

1.  Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity.

Authors:  M Rocheville; D C Lange; U Kumar; S C Patel; R C Patel; Y C Patel
Journal:  Science       Date:  2000-04-07       Impact factor: 47.728

2.  Recycling and resensitization of delta opioid receptors.

Authors:  N Trapaidze; I Gomes; M Bansinath; L A Devi
Journal:  DNA Cell Biol       Date:  2000-04       Impact factor: 3.311

3.  Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties.

Authors:  S R George; T Fan; Z Xie; R Tse; V Tam; G Varghese; B F O'Dowd
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

4.  Kappa opioid receptor endocytosis by dynorphin peptides.

Authors:  B A Jordan; S Cvejic; L A Devi
Journal:  DNA Cell Biol       Date:  2000-01       Impact factor: 3.311

5.  Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers.

Authors:  M Rocheville; D C Lange; U Kumar; R Sasi; R C Patel; Y C Patel
Journal:  J Biol Chem       Date:  2000-03-17       Impact factor: 5.157

6.  Coexpression of full-length gamma-aminobutyric acid(B) (GABA(B)) receptors with truncated receptors and metabotropic glutamate receptor 4 supports the GABA(B) heterodimer as the functional receptor.

Authors:  R Sullivan; A Chateauneuf; N Coulombe; L F Kolakowski; M P Johnson; T E Hebert; N Ethier; M Belley; K Metters; M Abramovitz; G P O'Neill; G Y Ng
Journal:  J Pharmacol Exp Ther       Date:  2000-05       Impact factor: 4.030

7.  Dopamine D1 and adenosine A1 receptors form functionally interacting heteromeric complexes.

Authors:  S Ginés; J Hillion; M Torvinen; S Le Crom; V Casadó; E I Canela; S Rondin; J Y Lew; S Watson; M Zoli; L F Agnati; P Verniera; C Lluis; S Ferré; K Fuxe; R Franco
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

8.  Anti-arrhythmic effect of kappa-opioid receptor stimulation in the perfused rat heart: involvement of a cAMP-dependent pathway.

Authors:  X C Yu; H X Wang; J M Pei; T M Wong
Journal:  J Mol Cell Cardiol       Date:  1999-10       Impact factor: 5.000

9.  Opioid receptor endocytosis and activation of MAP kinase pathway.

Authors:  N Trapaidze; I Gomes; S Cvejic; M Bansinath; L A Devi
Journal:  Brain Res Mol Brain Res       Date:  2000-03-29

10.  Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET).

Authors:  S Angers; A Salahpour; E Joly; S Hilairet; D Chelsky; M Dennis; M Bouvier
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more
  88 in total

1.  A single subunit (GB2) is required for G-protein activation by the heterodimeric GABA(B) receptor.

Authors:  Béatrice Duthey; Sara Caudron; Julie Perroy; Bernhard Bettler; Laurent Fagni; Jean-Philippe Pin; Laurent Prézeau
Journal:  J Biol Chem       Date:  2001-11-15       Impact factor: 5.157

2.  Heteromeric association creates a P2Y-like adenosine receptor.

Authors:  K Yoshioka; O Saitoh; H Nakata
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

Review 3.  Selective vulnerability of cerebellar granule neuroblasts and their progeny to drugs with abuse liability.

Authors:  Kurt F Hauser; Valeriya K Khurdayan; Robin J Goody; Avindra Nath; Alois Saria; James R Pauly
Journal:  Cerebellum       Date:  2003       Impact factor: 3.847

4.  Oligomeric size of the m2 muscarinic receptor in live cells as determined by quantitative fluorescence resonance energy transfer.

Authors:  Luca F Pisterzi; David B Jansma; John Georgiou; Michael J Woodside; Judy Tai-Chieh Chou; Stéphane Angers; Valerica Raicu; James W Wells
Journal:  J Biol Chem       Date:  2010-03-19       Impact factor: 5.157

5.  Consequences of opioid receptor mutation on actions of univalent and bivalent kappa and delta ligands.

Authors:  Michael A Ansonoff; Philip S Portoghese; John E Pintar
Journal:  Psychopharmacology (Berl)       Date:  2010-03-24       Impact factor: 4.530

Review 6.  Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes.

Authors:  Nicola J Smith; Graeme Milligan
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 7.  Thyrotropin receptor-associated diseases: from adenomata to Graves disease.

Authors:  Terry F Davies; Takao Ando; Reigh-Yi Lin; Yaron Tomer; Rauf Latif
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

8.  Differential distributions and trafficking properties of dopamine D1 and D5 receptors in nerve cells.

Authors:  You He; Lei-Ping Yu; Guo-Zhang Jin
Journal:  Neurosci Bull       Date:  2009-04       Impact factor: 5.203

9.  Requirement for direct cross-talk between B1 and B2 kinin receptors for the proliferation of androgen-insensitive prostate cancer PC3 cells.

Authors:  Liza Barki-Harrington; Angela L Bookout; Gaofeng Wang; Maria E Lamb; L M Fredrik Leeb-Lundberg; Yehia Daaka
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

10.  Direct interaction of GABAB receptors with M2 muscarinic receptors enhances muscarinic signaling.

Authors:  Stephanie B Boyer; Sinead M Clancy; Miho Terunuma; Raquel Revilla-Sanchez; Steven M Thomas; Stephen J Moss; Paul A Slesinger
Journal:  J Neurosci       Date:  2009-12-16       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.